SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-22-009662
Filing Date
2022-09-12
Accepted
2022-09-12 06:04:16
Documents
12
Period of Report
2022-09-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_090822.htm   iXBRL 8-K 32593
  Complete submission text file 0001387131-22-009662.txt   206234

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE admp-20220908.xsd EX-101.SCH 3266
3 XBRL LABEL FILE admp-20220908_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE admp-20220908_pre.xml EX-101.PRE 22385
6 EXTRACTED XBRL INSTANCE DOCUMENT admp-8k_090822_htm.xml XML 3589
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 221237302
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences